Full investment portfolio of the Relevant Investments as at 31 October 2023
| Relevant Investment | Type | Primary Listing | Country of Issuer | Currency | Total Cost | Mark-to-market Value | Weighting of GAV *(%) | Credit Rating (S&P's/Moody's/Fitch's) |
| NANFUN 4 ⅞ 05/29/24 EMTN | Bond | Singapore Exchange | BVI | USD | HK$56,602,000 | HK$53,037,000 | 0.0825% | BBB- / Baa3 / - |
| CAPG 6.35 02/08/24 | Bond | Singapore Exchange | Cayman Islands | USD | HK$38,747,000 | HK$655,000 | 0.0010% | - / - / - |
| CIFIHG 5.95 10/20/25 | Bond | Hong Kong Exchange | Cayman Islands | USD | HK$46,493,000 | HK3,042,000 | 0.0047% | - / - / - |
| SHUION 5 ¾ 11/12/23 | Bond | Singapore Exchange | Cayman Islands | USD | HK$33,282,000 | HK$38,322,000 | 0.0596% | - / - / - |
| HKE 2 ⅞ 05/03/26 | Bond | Hong Kong Exchange | BVI | USD | HK$7,758,000 | HK$7,323,000 | 0.0114% | A- / - / - |
| CKHH 1 ½ 04/15/26 | Bond | Singapore Exchange | Cayman Islands | USD | HK$14,530,000 | HK$14,159,000 | 0.0220% | A / A2 / A- |
| SWIPRO 3 ⅝ 01/13/26 | Bond | Hong Kong Exchange | Hong Kong | USD | HK$23,526,000 | HK$22,427,000 | 0.0349% | - / A2 / A |
| MOLAND 7 12/30/23 | Bond | Singapore Exchange | Cayman Islands | USD | HK$1,247,000 | HK$40,000 | 0.0001% | - / - / - |
| MOLAND 9 12/30/27 | Bond | Singapore Exchange | Cayman Islands | USD | HK$2,495,000 | HK$98,000 | 0.0002% | - / - / - |
| EC Healthcare (Stock Code: 2138.HK) | Equity | Hong Kong Exchange | Cayman Islands | HKD | HK$20,917,000 | HK$12,148,000 | 0.0189% | N/A |
| Total | HK$245,598,000 | HK$151,251,000 | 0.2353% | |||||